Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Biotech
Roche's $50B US investment to include upcoming Boston CVRM site
Roche also said this morning that some of the $50 billion would be used for the “significant expansion and upgrading” of three existing R&D centers.
James Waldron
Apr 22, 2025 5:10am
Merck & Co. pens $200M upfront deal for Hengrui med
Mar 25, 2025 9:10am
Roche to house its CVRM research work at new Boston hub
Mar 7, 2025 9:40am
Keros ends hypertension trial over fluid buildups around heart
Jan 15, 2025 8:25am
Cash-strapped Windtree seeks biotechs with FDA-approved products
Jan 9, 2025 4:44am
Keros halts 2 arms of hypertension trial over fluid near heart
Dec 12, 2024 6:30am
